Susquehanna International Group, LLP Eloxx Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.58 $31,920 - $77,140	-133,000 Reduced 91.66%	12,100 $3,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.0 $48,678 - $79,800	39,900 Added 37.93%	145,100 $237,000
Q2 2021 Aug 11, 2021	BUY	$1.35 - $3.36 $142,020 - $353,472	105,200 New	105,200 $209,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.